... Global LLC bought a new position in shares of Eiger Biopharmaceuticals during the 2nd quarter valued at $277,000. Ardsley Advisory Partners bought a new position in shares of Eiger Biopharmaceuticals during the 2nd quarter valued at $305,000. ...
https://sportsperspectives.com/2018/11/04/analysts-set-eiger-biopharmaceuticals-inc-eigr-target-price-at-32-67.html
No comments:
Post a Comment